Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr;20(4):209-227.
doi: 10.1038/s41574-023-00929-x. Epub 2024 Jan 25.

Iatrogenic adrenal insufficiency in adults

Affiliations
Review

Iatrogenic adrenal insufficiency in adults

Julie Martin-Grace et al. Nat Rev Endocrinol. 2024 Apr.

Abstract

Iatrogenic adrenal insufficiency (IAI) is the most common form of adrenal insufficiency in adult patients, although its overall exact prevalence remains unclear. IAI is associated with adverse clinical outcomes, including adrenal crisis, impaired quality of life and increased mortality; therefore, it is imperative that clinicians maintain a high index of suspicion in patients at risk of IAI to facilitate timely diagnosis and appropriate management. Herein, we review the major causes, clinical consequences, diagnosis and care of patients with IAI. The management of IAI, particularly glucocorticoid-induced (or tertiary) adrenal insufficiency, can be particularly challenging, and the provision of adequate glucocorticoid replacement must be balanced against minimizing the cardiometabolic effects of excess glucocorticoid exposure and optimizing recovery of the hypothalamic-pituitary-adrenal axis. We review current treatment strategies and their limitations and discuss developments in optimizing treatment of IAI. This comprehensive Review aims to aid clinicians in identifying who is at risk of IAI, how to approach screening of at-risk populations and how to treat patients with IAI, with a focus on emergency management and prevention of an adrenal crisis.

PubMed Disclaimer

References

    1. Arlt, W. & Allolio, B. Adrenal insufficiency. Lancet 361, 1881–1893 (2003). - PubMed - DOI
    1. Bornstein, S. R. Predisposing factors for adrenal insufficiency. N. Engl. J. Med. 360, 2328–2339 (2009). - PubMed - DOI
    1. Björnsdottir, S. et al. Drug prescription patterns in patients with Addison’s disease: a Swedish population-based cohort study. J. Clin. Endocrinol. Metab. 98, 2009–2018 (2013). - PubMed - DOI
    1. Erichsen, M. M. et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J. Clin. Endocrinol. Metab. 94, 4882–4890 (2009). - PubMed - DOI
    1. Olafsson, A. S. & Sigurjonsdottir, H. A. Increasing prevalence of Addison disease: results from a nationwide study. Endocr. Pract. 22, 30–35 (2016). - PubMed - DOI

Substances

LinkOut - more resources